ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants

Clinical trial NCT06787144 · RECRUITING

Trial details

NCT number: NCT06787144
Sponsor: Enliven Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

CML (Chronic Myelogenous Leukemia)Chronic Phase CML

Start date: 2025-01-23
Primary completion: 2028-01-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.